Saint Boniface Hospital is Manitoba's second-largest hospital, located in the Saint Boniface neighbourhood of Winnipeg. Founded by the Sisters of Charity of Montreal in 1871, it was the first hospital in Western Canada. The hospital was incorporated in 1960, and as of 2003 has 554 beds and 78 bassinets.

There are 554 (78 nursing bassinets) beds in St. Boniface General Hospital.

During the past decade, St. Boniface General Hospital conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 28 clinical trials were completed, i.e. on average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 8 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Boniface General Hospital" #1 sponsor was "University of Manitoba" with 51 trials, followed by "St. Boniface Hospital" with 8 trials sponsored, "Boehringer Ingelheim" with 6 trials sponsored, "McMaster University" with 5 trials sponsored and "Pfizer" with 5 trials sponsored. Other sponsors include 110 different institutions and companies that sponsored additional 94 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Boniface General Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 31 trials as a collaborator, "St. Boniface Hospital" with 10 trials as a collaborator, "Foothills Medical Centre" with 5 trials as a collaborator, "Manitoba Medical Service Foundation" with 5 trials as a collaborator and "Eli Lilly and Company" with 4 trials as a collaborator. Other collaborators include 225 different institutions and companies that were collaborators in the rest 167 trials.

According to Clinical.Site data, the most researched conditions in "St. Boniface General Hospital" are "Heart Failure" (13 trials), "Myocardial Infarction" (9 trials), "Atrial Fibrillation" (5 trials), "Respiratory Distress Syndrome" (4 trials) and "Acute Kidney Injury" (3 trials). Many other conditions were trialed in "St. Boniface General Hospital" in a lesser frequency.

Most popular intervention types in "St. Boniface General Hospital" are "Drug" (83 trials), "Device" (37 trials), "Other" (31 trials), "Procedure" (17 trials) and "Behavioral" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Empagliflozin" (4 trials), "Aspirin" (3 trials), "Amantadine" (2 trials) and "Convalescent plasma" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Boniface General Hospital" are 179 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "St. Boniface General Hospital". 2 are not yet recruiting, 24 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 98 completed trials in St. Boniface General Hospital, 6 suspended trials, and 30 terminated clinical trials to date.

Out of the total trials that were conducted in St. Boniface General Hospital, 4 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 60 trials that are defined as “Not Applicable".